Advertisement
Parent training intervention leads to significant improvement in sleep problems
Up to 80% of children with autism spectrum disorder (ASD) also have at least moderate sleep disturbances. Disordered sleep in children with autism can amplify already delayed social interactions, repetitive behaviors, affective problems, inattention/hyperactivity and irritability.
Advertisement
Cleveland Clinic is a non-profit academic medical center. Advertising on our site helps support our mission. We do not endorse non-Cleveland Clinic products or services. Policy
In a prior NIH-funded study (R34MH082882), the principal investigator, Cynthia R. Johnson, PhD, Director of the Cleveland Clinic Children’s Center for Autism, showed that a five-session, individually delivered parent training intervention for young children with ASD and sleep disturbances resulted in significant improvements in sleep problems compared with the control group, which received five sessions of an education program relevant to young children with ASD.1
This study was delivered in a tertiary, specialized setting requiring parents to make many trips to an urban area; some families traveled over two hours to participate. Now, with funding from the Department of Defense, Dr. Johnson and her team will further test this manualized parent training program specifically targeting bedtime and sleep disturbance but delivered via a telehealth platform. This four-year randomized control trial is actively recruiting (email autismresearch@ccf.org for more information). If we demonstrate that this manualized parent training program specifically targeting sleep disturbances can be delivered with fidelity and efficacy via a telehealth platform, this has broad implications for clinical service delivery to reach children and families living at a distance from a specialized autism center.
Advertisement
Advertisement
Long-awaited efficacy against disability progression appears to be at hand
Extension of DELIVER-MS trial will clarify long-term clinical effects of dueling treatment philosophies
Dopamine agonist performs in patients with early stage and advanced disease
A flow of dehumidified room air delivered via at-home device modulates sphenopalatine ganglion
BTK inhibitor tolebrutinib shows positive results in phase 3 HERCULES trial
Phenotypic clustering study reveals four distinct disease trajectories
A host of factors shape when to intervene and which of three primary procedures to use
Validated scale provides a method for understanding how lifestyle may protect against Alzheimer's